UroGen Pharma (URGN) Capital Expenditures (2016 - 2026)
UroGen Pharma (URGN) reported Capital Expenditures of $60,000 for Q2 2026, down 57.4% from $141,000 a year earlier but up 11.1% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Capital Expenditures (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, UroGen Pharma's Capital Expenditures came in at $218,000, down 44.9% year-over-year; for FY2025, it came in at $289,000, down 2.0% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -25.0% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $295,000 in FY2024 (+52.1%), $194,000 in FY2023 (-23.6%), $254,000 in FY2022 (-66.2%) and $752,000 in FY2021 (-38.1%).
- Five-year quarterly Capital Expenditures spans a low of $13,000 in Q4 2022 and a high of $202,000 in Q4 2021.
- Year over year, Capital Expenditures gained in three of the last seven quarters, with growth averaging 5.7%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2024 (growth of 460.0%); the low point was Q4 2022 (a decline of 93.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $54,000 (Q1 2026), $17,000 (Q4 2025) and $87,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | UroGen Pharma | 1.24 Bn | 782.15 Mn | 81.50 Mn | 72,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 72,000.00 |
| Jun 30, 2026 | 60,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 63,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 202,000.00 |
| Sep 30, 2021 | 194,000.00 |
API Access
UroGen Pharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();